Cancer Screening
Cancer remains a significant concern in pets, with 1 in 4 dogs being diagnosed with cancer in their lifetime. Thanks to the advancements in science and technology, groundbreaking diagnostic cancer tests for dogs have been developed, similar to those available for humans. These tests can detect abnormal elevations in specific proteins, indicating the presence of a cancerous condition.
To better understand cancer screening for dogs, it is essential to grasp the concepts of tumors and cancer. A tumor is a mass of abnormal cells that can develop either benignly or malignantly. Benign tumors are growths that remain localized and do not invade surrounding tissues, while malignant tumors, or cancer, are characterized by uncontrolled growth that can spread and damage organs. Cancer becomes even more concerning when it metastasizes, spreading to vital parts of the body.
While not all tumors are cancerous, all cancer cases are not necessarily characterized by tumor growth. For instance, leukemia is a type of cancer that affects the blood without the presence of a solid tumor. In cases where a tumor is present, a biopsy is crucial to determine whether it is benign or malignant.
In the realm of cancer screening for pets, particularly dogs, there have been significant advancements. Tests such as the Nu.Q Canine Cancer screening test, available through Idexx laboratories, offer early detection of certain cancers in dogs. This blood test measures canine plasma nucleosome concentrations, which are combinations of DNA and specific proteins. The Nu.Q Cancer Screen test is recommended for healthy dogs over the age of 7 years, as well as breeds with an increased risk of cancer that are 4 years and older. It is important that the dogs undergoing the test are not experiencing systemic infections or on immunosuppressive drugs to avoid false positive results.
The Nu.Q Cancer Screen test is a straightforward process that requires the pet to fast for 8 to 12 hours before the appointment. The test is typically conducted Monday through Thursday, preferably before noon, to ensure rapid arrival at the testing laboratory. A blood sample is obtained from the pet, and for dogs that may require anti-anxiety medication, it is advised to administer it with minimal food to prevent interference with the results.
Currently, there are no specific blood tests available for cancer screening in cats, unlike those available for dogs. However, researchers are actively working on developing a simple and affordable test for feline cancer detection. In the absence of dedicated screening tests, veterinarians rely on imaging techniques such as x-rays and ultrasound, as well as bloodwork, to assess cats for signs of cancer. It is important to be vigilant for any potential symptoms in cats and seek prompt veterinary attention if any concerning signs emerge. With ongoing advancements in veterinary medicine, the hope is to provide better and more accessible screening options for our beloved feline companions in the future.
The Nu.Q Canine Cancer Screen test represents a significant advancement in early cancer screening for dogs. By providing early detection before symptoms manifest, this test opens up opportunities for better treatment options, ultimately leading to a longer and quality-filled life for our beloved canine companions.
Costs: Clients are welcome to choose to only have the Nu.Q Cancer screen performed but we do suggest an annual blood panel to check other health parameters for pets such as liver and kidney function. Metabolic and endocrine diseases can be just as debilitating as cancer.
Office Visit for Well Pet: 53.00
Nu.Q. Cancer Screen Test: 140.00
Total Health with Urinalysis (recommended for pets under 7 years): 174.00
Senior Screen with Free T4 (recommended for pets 7 years and older): 188.00
Senior Screen with Cardiopet (recommended for senior pets with concerns for heart disease) : 315.00
Depending on your pets unique needs, we can customize lab panels to optimize obtaining the best information needed.
Frequently Asked Questions regarding Nu.Q. Cancer Screen Testing:
What species can this test be used on?
Currently, the Nu.0® Vet Cancer Test is validated exclusively for dogs.
When should dogs be tested?
The Nu.Q Vet Cancer Test is ideal for regular wellness checks, particularly in senior dogs aged 7 years and older. For breeds with a higher cancer risk, dogs as young as 4 years can benefit from this test. Breeds like Labrador Retrievers, French Bulldogs, and Golden Retrievers, to name a few, can greatly benefit from the preventive insights this test provides.
Is the Nu.Q Vet Cancer Test suitable for patients with concurrent disease?
As a screening tool, the Nu.Q Vet Cancer Test is suited for healthy, asymptomatic patients during routine wellness visits. However, it’s worth noting that certain conditions, such as immune-mediated diseases or trauma, can influence test results. Thus, when evaluating patients with recent diagnoses or those presenting with unstable conditions, these factors should be carefully considered prior to testing.
Are there any medications that interfere with the Nu.Q Vet Cancer Test results?
Based on our data, common medications such as Trazodone and NSAIDs (e.g., Rimadyl or carprofen) do not impact the test’s accuracy. However, for glucocorticoids like prednisone, may or may not affect the concentration of nucleosomes; therefore, we recommend the patient be steroid-free for a period of 7-10 days prior to testing
Do pre-existing or other clinical conditions impact the results of the Nu.Q® Vet Cancer Test?
Our current research suggests managed conditions like chronic inflammation or hypothyroidism, for example, do not influence the Nu.0® Vet Cancer Test results. It’s always recommended to consider the complete health profile of the patient for the most comprehensive understanding.
Will this test specify the type of cancer my dog has?
No, it cannot tell you the specific type of cancer but a 97% specificity the Nu.Q Vet Cancer test is adept at detecting a significant percentage of systemic cancers. For instance, it determines lymphoma at 77% sensitivity, hemangiosarcoma at 82% and histiocytic sarcoma at 54%.
What can the test not detect?
The Nu.Q Vet Cancer Screen cannot detect solid single tumors that are only locally present. Example: Mast cell tumors of the skin or Melanoma, these are typically tumors first but with time can become cancerous. The Nu.Q Cancer test screens for cancers that are systemic before symptoms arise.
Are other tests needed to look for cancer?
Yes, if your pet has symptoms such as limping or breathing problems or an obvious mass arises, x-rays and biopsy would be recommended.
